Enzene’s two facilities in Pune, India have received European Union (EU) GMP certification to provide commercial-scale ...

Following a year of strategic expansion, European medicine-related companies are advancing their operations in Vietnam.

Symbiosis’ completion of the FDA regulatory review is expected to increase the company’s commercial-scale sterile manufacturing capabilities.

The company received a certificate of Good Manufacturing Practice (GMP) compliance following an inspection of their Montreal facility by the European Medicines Agency MONTRÉAL, Feb. 19 ...

The company received a certificate of Good Manufacturing Practice (GMP) compliance following an inspection of their Montreal facility by the European Medicines Agency MONTRÉAL, Feb. 19, 2025 (GLOBE ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr ...

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced it will be presenting next week at Terrapinn’s Advanced Therapies Congress 2025, held in London. Ibon ...

Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint venture ...

Pharma sector is at a tipping point, with potential to become a global leader through agile, efficient, and sustainable operations, says the report ...